Aurora® Biotechnologies Introduces Unique 384-Well Microplates for Imaging and High-Content Screening Applications
30 Jan 2008Aurora® Biotechnologies today announced that it has formally launched a new series of 384-well microplates for the life science research market. The 384-IQ™ microplates are optimal for imaging and high-content screening applications.
“We are thrilled to provide the research marketplace an extension of our inimitable and valuable microplate designs in a 384-well format. The use of Cyclo-Olefin Polymer (COP) has proven to enhance performance in many sensitive assays, and has worked very well for high-content imaging,” stated Peter Coassin, CTO, Aurora Biotechnologies. “Our new products address the demanding needs of the imaging and HCS scientists who require a high-performing imaging microplate with extraordinary flatness and optical clarity properties, at a price point superior to other comparable microplate options.”
The 384-IQ™ microplates are available in black, white, and clear with options for solid or film bottoms. The new microplates also offer a unique Evaporation Barrier Well Design for the control of evaporative edge effects. The microplates are available with either chamfered-square wells or low volume round wells. All plate configurations meet SBS and ANSI standard requirements. The new 384-well microplates are made from the same high-performance COP that is exclusive to Aurora Biotechnologies’ current 1536-well and 3456-well microplate products.